EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbiome dynamics in immune checkpoint blockade

Chae Won Kim, Hyun-Jin Kim, Heung Kyu Lee

Trends in Endocrinology & Metabolism · 2024-11 · 35 (11) · 996-1005

DOI: 10.1016/j.tem.2024.04.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2024-11. Verfasst von Chae Won Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea; Life Science Instit…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, Ministry of Science and ICT, South Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint blockade (ICB) is one of the leading immunotherapies, although a variable extent of resistance has been observed among patients and across cancer types. Among the efforts underway to overcome this challenge, the microbiome has emerged as a factor affecting the responsiveness and efficacy of ICB. Active research, facilitated by advances in sequencing techniques, is assessing the predominant influence of the intestinal microbiome, as well as the effects of the presence of an intratumoral microbiome. In this review, we describe recent findings from clinical trials, observational studies of human patients, and animal studies on the impact of the microbiome on the efficacy of ICB, highlighting the role of the intestinal and tumor microbiomes and the contribution of methodological advances in their study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsGastrointestinal MicrobiomeHumansAnimalsImmunotherapyMicrobiota

Stichwörter der Autor:innen

cancerimmune checkpoint blockadeimmunotherapymicrobiome

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea; Life Science Institute, KAIST, Daejeon 34141, Republic of Korea.
  • Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea. Electronic address: heungkyu.lee@kaist.ac.kr.

Förderung

  • Ministry of Science, ICT and Future Planning
  • Ministry of Science and ICT, South Korea
  • National Research Foundation of Korea

Zitieren

APA

Kim, C. W., Kim, H. J., & Lee, H. K. (2024). Microbiome dynamics in immune checkpoint blockade. Trends in Endocrinology & Metabolism, 35(11), 996-1005. https://doi.org/10.1016/j.tem.2024.04.013

Vancouver

Kim CW, Kim HJ, Lee HK. Microbiome dynamics in immune checkpoint blockade. Trends in Endocrinology & Metabolism. 2024;35(11):996-1005. doi:10.1016/j.tem.2024.04.013

BibTeX
@article{Kim2024,
  author = {Kim, Chae Won and Kim, Hyun-Jin and Lee, Heung Kyu},
  title = {Microbiome dynamics in immune checkpoint blockade},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2024},
  volume = {35},
  number = {11},
  pages = {996--1005},
  doi = {10.1016/j.tem.2024.04.013}
}
Kostenlos starten →